Neuphoria Therapeutics NEUP
NASDAQ NEUP
$3.56 -0.01 (-0.28%)
At close: Sep 30, 2026 · 4:00 PM EDT

Neuphoria Therapeutics (NEUP) Net Margin (2024 - 2025)

Updated

Neuphoria Therapeutics (NEUP) reported Net Margin of -1149.75% for FY2026 (year ended Jun 30, 2026), down 1147.20 percentage points from -2.56% in FY2025.

Analysis

Neuphoria Therapeutics (NEUP) Net Margin (2024 - 2025) Analysis & Trends

Dating back to FY2020, Neuphoria Therapeutics' Net Margin record includes 5 fiscal years.

  • Net Margin has a four-year change of -1496.21 percentage points (FY2022 to FY2026).
  • The FY2026 figure ranks as the lowest annual Net Margin since FY2023.
  • According to Business Quant data, Net Margin came in at -2.56% in FY2025, -144450.30% in FY2023 (-144796.75 pp) and 346.45% in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 21.86%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 21.27%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -8.04%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 22.61%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 18.81%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 23.62%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -134.51%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 32.99%
10 Neuphoria Therapeutics 443.79 Mn 368.60 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 75.33%
Dec 31, 2024 -293.24%
API Access

Neuphoria Therapeutics Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=NEUP&period=max&api_key=YOUR_API_KEY